Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin for Candida or Aspergillus infections in China
NCT02646800Phase 4Terminated
- Sponsor
- Astellas Pharma
- Start
- Mar 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of micafungin in candidiasis, aspergillosis, sponsored by Astellas Pharma. Started Mar 2014; status: terminated.
02
Drugs
micafungin
03
Conditions
candidiasisaspergillosis
Beyond the preview
Go deeper on NCT02646800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02646800.